Development of novel salicylic acid–donepezil–rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

Development of novel salicylic acid–donepezil–rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease

Published:2023-07-06 Issue:1 Volume:38 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Zhou Yi¹,He Ying¹,Teng Xue²,Mi Jing¹,Yang Jing¹,Wei Rongrui³,Liu Wenmin¹,Ma Qinge³,Tan Zhenghuai⁴,Sang Zhipei¹²

Affiliation:

1. College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, China

2. Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou, China

3. Key Laboratory of Modern Preparation of Traditional Chinese Medicine of Ministry of Education, Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, China

4. Institute of Traditional Chinese Medicine Pharmacology and Toxicology, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China

Funder

Science and Technology Project of Henan Province

The Special Project of Nanyang Normal University

The Fundamental Research Funds for Hainan University

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2231661

Reference29 articles.

1. Alzheimer's disease

2. World Alzheimer Report 2019: attitudes to dementia. Alzheimer’s Disease International; 2019. p. 1–13. https://www.alz.co.uk/research/world-report-2019.

3. Alzheimer's disease drug development pipeline: 2021

4. Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

5. Multi-target design strategies for the improved treatment of Alzheimer's disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy;Bioorganic Chemistry;2024-10

2. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands;European Journal of Medicinal Chemistry;2024-09

3. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease;Bioorganic Chemistry;2024-03

4. Development of novel chalcone derivatives as multifunctional agents for the treatment of Alzheimer’s disease;Medicinal Chemistry Research;2024-02-26